Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. IQVIA Holdings Inc.
  6. Summary
    IQV   US46266C1053

IQVIA HOLDINGS INC.

(IQV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
233.2(c) 234.82(c) 239.38(c) 242.8(c) 243.44(c) Last
1 608 560 777 082 1 049 859 799 852 1 089 092 Volume
-0.27% +0.69% +1.94% +1.43% +0.26% Change
More quotes
Financials (USD)
Sales 2021 13 423 M - -
Net income 2021 808 M - -
Net Debt 2021 10 018 M - -
P/E ratio 2021 58,6x
Yield 2021 -
Sales 2022 14 540 M - -
Net income 2022 1 021 M - -
Net Debt 2022 9 405 M - -
P/E ratio 2022 45,7x
Yield 2022 -
Capitalization 46 658 M 46 658 M -
EV / Sales 2021 4,22x
EV / Sales 2022 3,86x
Nbr of Employees 72 000
Free-Float 74,2%
More Financials
Company
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions,... 
Read more
More about the company
Ratings of IQVIA Holdings Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about IQVIA HOLDINGS INC.
06/11IPSEN  : Finds Potential Treatment Gap Among Spasticity Patients in US
MT
06/08IQVIA  : Q2 Solutions and Tasso Collaborate to Provide Unique Solutions for Pati..
BU
06/04PRESS RELEASE : Novartis announces Tabrecta(R) -2-
DJ
06/03IQVIA  : Global Oncology Innovation Continues Despite Pandemic; Global R&D Pipel..
BU
05/26PRESS RELEASE : Marinomed Biotech AG Reports Financial Results for 1st Quarter 2..
DJ
05/20IQVIA  : CFO, Ron Bruehlman, to Speak at the William Blair Growth Stock Conferen..
BU
05/19IQVIA  : Pharma R&D Activity Surges Even Without COVID-19, Says Report from the ..
BU
05/17PRESS RELEASE : Novartis: US Supreme Court denies Sandoz petition to review bios..
DJ
05/14IQVIA  : KeyBanc Adjusts IQVIA Holdings' Price Target to $260 From $255, Keeps O..
MT
05/13MOVES-Deutsche Bank hires investment banking veteran Priyanka Verma in health..
RE
05/13Top scientists question the need for COVID-19 booster shots
RE
05/12IQVIA  : Argus Adjusts IQVIA Holdings' Price Target to $260 From $220, Keeps Buy..
MT
05/12DR REDDY LABORATORIES  : Launches Generic Invanz in US
MT
05/11VEEVA  : Accuses IQVIA of 'False And Intentionally Misleading' Lawsuit-Related P..
MT
05/10IQVIA  : Gets Favorable Ruling in Lawsuit Against Veeva
MT
More news
News in other languages on IQVIA HOLDINGS INC.
05/26DGAP-NEWS : Marinomed Biotech AG berichtet Finanzergebnisse für das 1. Quartal 2..
03/24L'agenda di domani
03/24J&J  : de nouvelles collaborations contre la tuberculose
03/24L'agenda della settimana
02/23GENFIT  : une étude souligne le potentiel d'elafibranor
More news
Analyst Recommendations on IQVIA HOLDINGS INC.
More recommendations
Chart IQVIA HOLDINGS INC.
Duration : Period :
IQVIA Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IQVIA HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Average target price 257,25 $
Last Close Price 243,44 $
Spread / Highest target 15,0%
Spread / Average Target 5,67%
Spread / Lowest Target -16,2%
EPS Revisions
Managers and Directors
NameTitle
Ari Bousbib Chairman, President & Chief Executive Officer
Ronald Earl Bruehlman Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
W. Richard Staub President-Research & Development Solutions
Kevin C. Knightly President-Technology & Commercial Solutions
Sector and Competitors
1st jan.Capitalization (M$)
IQVIA HOLDINGS INC.35.87%46 658
MODERNA, INC.109.49%87 874
LONZA GROUP AG16.32%54 656
CELLTRION, INC.-26.04%32 458
SEAGEN INC.-10.60%28 416
HANGZHOU TIGERMED CONSULTING CO., LTD13.85%24 128